Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

Positive findings from two clinical trials have been published for the immunomodulatory agent lenalidomide in patients with heavily pretreated mantle cell lymphoma, and in adults with T-cell leukaemia–lymphoma or peripheral T-cell lymphoma.
Source: MedWire News - Category: Consumer Health News Tags: Leukaemia Source Type: news